Cancer drug being repurposed to treat Fragile X Syndrome
Researchers at UW-Madison are trying to repurpose an antitumor drug to treat a common intellectual disability known as Fragile X Syndrome. And Professor Xinyu Zhao, a professor of neuroscience at UW-Madison who’s heading up this research, says initial tests in